Martha Taboada, MD
I chose the specialty of pediatric endocrinology because it’s a very exciting field with new advances in diagnoses and therapies that are evolving on a daily basis. I also enjoy the challenge of diagnosing and treating children with hormonal problems. My work encompasses a wide range of conditions: diabetes, precocious puberty, growth disorders, thyroid disorders, polycystic ovarian syndrome and Turner syndrome. I have a particular interest in disorders of puberty, Turner syndrome, growth disorders and endocrine disorders after cancer therapy.
Being able to help others is the best aspect of being a doctor. My patients are my priority. I’ll always do my best to listen to their concerns and do what’s necessary in order to help them. Children are honest and fun. I love that I get to interact with children of all ages and their families, and see my patients grow and develop physically and mentally. It is very gratifying to see them get better and become healthy adults.
I am proud to support the Juvenile Diabetes Research Foundation, an organization that funds diabetes research.
When I’m not working, I like spending time with my husband and son, taking bike rides, going to the park and watching movies.Related Medical Services
Meet Dr. Taboada
- Universidad Del Norte, 2002
- University Of Kansas Medical Center, 2007, Pediatrics
- University Of Florida At Jacksonville, 2010, Pediatric Endocrinology
- American Board of Pediatrics-Pediatric Endocrinology
- American Board of Pediatrics-Pediatrics
- The Pediatric Endocrine Society
- The Endocrine Society
- A missense mutation of the thyroid hormone receptor beta (THRB) in a child with Down Syndrome (DS). Abstract presentation at LWPES/ESPE 8th Joint Meeting. New York, N.Y., USA
- The challenge of mistaken sex assignment in an 11 year old with virilizing CAH. Abstract presentation at 2nd World Conference: Hormonal and Genetic Basis of Sexual Differentiation Disorders and Hot Topics in Endocrinology. Miami, FL
- Pharmacokinetics (PK) and pharmacodynamics (PD) of oral and transdermal 17β estradiol (E2) in Turner Syndrome (TS). Presented at the 2011 PAS/ASPR meeting in Denver, Colorado
- “Going Beyond X and Y”, Pediatric Grand Rounds, Wolfson’s Children Hospital, Jacksonville, Fl, 2009
- “Turner Syndrome: The Importance of Early Recognition for Improved Outcomes,” Pediatric Grand Rounds, Nemours Children’s Hospital, Orlando, Fl, 2013